<?xml version="1.0" encoding="UTF-8"?>
<abstract id="16339217">
  <title>
    <s id="0" section="title">
      Economic evaluation of a
      <group id="0">
        <short>general  practitioner  with  special  interests</short>
        led  dermatology  service
      </group>
      in primary care .
    </s>
  </title>
  <annotated>
    <s id="3" section="setting">General practitioner with special interest dermatology service covering 29 general practices in Bristol .</s>
    <s id="5" section="interventions">
      Participants were randomised 2 : 1 to receive either
      <group id="0">
        care  by
        <short>general  practitioner  with  special  interest</short>
        service
      </group>
      or
      <group id="1">usual  hospital  outpatient  care</group>
      .
    </s>
    <s id="7" section="main_outcome_measures">
      <outcome id="4">Cost  effectiveness</outcome>
      , using the 2 primary outcomes of
      <outcome id="4:0">dermatology  life  quality  index  scores</outcome>
      and
      <outcome id="4:1">
        improved
        <short>patient  perceived  access</short>
      </outcome>
      , was assessed by
      <outcome id="4:2">incremental  cost  effectiveness  ratios</outcome>
      and
      <outcome id="4:3">cost  effectiveness  acceptability  curves</outcome>
      .
    </s>
    <s id="9" section="results">
      <outcome id="0">Costs  to  the  NHS</outcome>
      for
      <group id="0">patients  attending  the  general  practitioner  with  special  interest  service</group>
      were 208 pounds sterling ( 361 dollars ; 308 euro ) compared with 118 pounds sterling for
      <group id="1">hospital  outpatient  care</group>
      .
    </s>
    <s id="10" section="results">
      Based on analysis with imputation of missing data ,
      <outcome id="1">costs  to  patients</outcome>
      and
      <outcome id="2">companions</outcome>
      were 48 pounds sterling and 51 pounds sterling , respectively ;
      <outcome id="3">costs  of  lost  production</outcome>
      were 27 pounds sterling and 34 pounds sterling , respectively .
    </s>
    <s id="11" section="results">
      The
      <outcome id="4:2">incremental  cost  effectiveness  ratios</outcome>
      for
      <group id="0">general  practitioner  with  special  interest  care</group>
      over
      <group id="1">outpatient  care</group>
      were 540 pounds sterling per 1 point gain in the
      <outcome id="4:0">dermatology  life  quality  index</outcome>
      and 66 pounds sterling per 10 point change in the
      <outcome id="4:1">access  scale</outcome>
      .
    </s>
  </annotated>
  <fulltext>Economic evaluation of a general practitioner with special interests led dermatology service in primary care . To carry out an economic evaluation of a general practitioner with special interest service for non - urgent skin problems compared with hospital outpatient care . Cost effectiveness analysis and cost consequences analysis alongside a randomised controlled trial . General practitioner with special interest dermatology service covering 29 general practices in Bristol . Adults referred to a hospital dermatology clinic who were potentially suitable for management by a general practitioner with special interest . Participants were randomised 2 : 1 to receive either care by general practitioner with special interest service or usual hospital outpatient care . Costs to NHS , patients , and companions , and costs of lost production . Cost effectiveness , using the 2 primary outcomes of dermatology life quality index scores and improved patient perceived access , was assessed by incremental cost effectiveness ratios and cost effectiveness acceptability curves . Cost consequences are presented in relation to all costs and both primary and secondary outcomes from the trial . Costs to the NHS for patients attending the general practitioner with special interest service were 208 pounds sterling ( 361 dollars ; 308 euro ) compared with 118 pounds sterling for hospital outpatient care . Based on analysis with imputation of missing data , costs to patients and companions were 48 pounds sterling and 51 pounds sterling , respectively ; costs of lost production were 27 pounds sterling and 34 pounds sterling , respectively . The incremental cost effectiveness ratios for general practitioner with special interest care over outpatient care were 540 pounds sterling per 1 point gain in the dermatology life quality index and 66 pounds sterling per 10 point change in the access scale . The general practitioner with special interest service for dermatology is more costly than hospital outpatient care , but this additional cost needs to be weighed against improved access and broadly similar health outcomes .</fulltext>
  <ignored>
    <s id="1" section="objective">
      To carry out an economic evaluation of a
      <group id="0">
        <short>general  practitioner  with  special  interest</short>
        service  for  non  -  urgent  skin  problems
      </group>
      compared with
      <group id="1">hospital  outpatient  care</group>
      .
    </s>
    <s id="2" section="design">Cost effectiveness analysis and cost consequences analysis alongside a randomised controlled trial .</s>
    <s id="4" section="participants">
      Adults referred to a hospital dermatology clinic who were potentially suitable for
      <group id="0">
        management  by  a
        <short>general  practitioner  with  special  interest</short>
      </group>
      .
    </s>
    <s id="6" section="main_outcome_measures">
      <outcome id="0">Costs  to  NHS</outcome>
      ,
      <outcome id="1">patients</outcome>
      , and
      <outcome id="2">companions</outcome>
      , and
      <outcome id="3">costs  of  lost  production</outcome>
      .
    </s>
    <s id="8" section="main_outcome_measures">Cost consequences are presented in relation to all costs and both primary and secondary outcomes from the trial .</s>
    <s id="12" section="conclusions">
      The
      <group id="0">
        <short>general  practitioner  with  special  interest</short>
        service  for  dermatology
      </group>
      is more costly than
      <group id="1">hospital  outpatient  care</group>
      , but this additional cost needs to be weighed against
      <outcome id="5">improved  access</outcome>
      and
      <outcome id="6">broadly  similar  health  outcomes</outcome>
      .
    </s>
  </ignored>
</abstract>

